#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    CDKL5 deficiency disorder Oesophageal atresia Huntington's disease Spinal muscular atrophy Fibrodysplasia ossificans progressiva Testicular leiomyosarcoma Wolfram syndrome Myelin oligodendrocyte glycoprotein antibody-associated disease Hyperinsulinism Extraskeletal ossification Chronic kidney disease Von Hippel-Lindau disease Fms-like tyrosine kinase 3 positive Ventricular tachycardia Autologous haematopoietic stem cell transplant More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome – Treatment Alternating hemiplegia of childhood – Trials in Disease Castleman’s disease – Treatment Factor IX deficiency – Treatment Behcet’s syndrome – Diagnostics Mantle cell lymphoma Splenic marginal zone lymphoma – Treatment Nephrotic syndrome – Life with Disease Mucopolysaccharidosis Choroid melanoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metolazone Dexamethasone Sodium Phosphate Gsk6097608 Dnth103 Cisatracurium Besilate ALN-961583 Cefepime Tamuzimod Acetate ABIRATERONE DECANOATE Terlipressin Acetate Forimtamig Cariprazine Cetuximab Calcitriol Hydrocortisone SAT-3247 OXALATE Teicoplanin Regadenoson Regtivex Wt1 Lamp Mrna Dc More therapies…

    Learn about Your Condition

    Aortic aneurysm Hypothyroidism Diabetic nephropathy Muscle strain Small intestine leiomyosarcoma Thromboangiitis obliterans Dry eye Cerebral haemorrhage KBG syndrome Thalassaemia alpha Dupuytren's contracture Heparin resistance Oxygen saturation Brain abscess Tumour of ampulla of Vater More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac ventricular thrombosis
    • Acute myocardial infarction
    Investigated Drugs:
    • Sulfur Hexafluoride
    • Perflutren
    • Warfarin Sodium
    Denmark Sweden

  • Study on Colchicine for Patients with Knee or Hip Osteoarthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Colchicine
    The Netherlands

  • Study on Alkaline Phosphatase for Reducing Kidney Transplant Complications in Patients with End-Stage Kidney Disease

    Recruiting

    2 1
    Investigated Diseases:
    • End stage renal disease
    • Reperfusion injury
    Investigated Drugs:
    • Alkaline Phosphatase, Bovine
    The Netherlands

  • Study on Indocyanine Green for Patients Undergoing Emergency Surgery for Acute Cholecystitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholecystitis acute
    Investigated Drugs:
    • Indocyanine Green
    Spain

  • Study of NVL-655 for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with ALK Mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Nvl-655
    Belgium France Germany Italy The Netherlands Spain

  • Study of alfacalcidol for treating secondary hyperparathyroidism in patients after gastric bypass surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperparathyroidism secondary
    Investigated Drugs:
    • Alfacalcidol
    The Netherlands
Previous Page
1 … 401 402 403 404 405 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!